These results were further supported by therapeutic studies of the KPC2/FVB model in which combined therapy with AZD1390, radiation, and anti–PD-L1 significantly inhibited tumor growth, albeit with a greater therapeutic effect of radiation and anti–PD-L1 than observed in mT4 tumors (Supplemental Figure 3, C–E). This evidence concerns the gene CD274 and neoplasm.